The Effect of Motivational Interviewing on the Level of Self-Efficacy and Addiction in Smoking Cessation

April 27, 2023 updated by: Hacer Gok Ugur, T.C. ORDU ÜNİVERSİTESİ

The Effect of Motivational Interviewing on the Level of Self-Efficacy and Addiction in Smoking Cessation in Nursing Students: A Single-Blind Randomized Controlled Study

This study will be carried out to determine the effect of motivational interviewing on the level of self-efficacy and addiction in smoking cessation in nursing students.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study will be carried out to determine the effect of motivational interviewing on the level of self-efficacy and addiction in smoking cessation in nursing students. The study was planned as a single-blind randomized controlled experimental study. The population of the research will be composed of students studying in the 1st, 2nd and 3rd years of Ordu University and Giresun University Faculty of Health Sciences Nursing Department and who meet the research criteria, and the sample will be 90 students determined by power analysis. In the study, 30 students from Ordu University Faculty of Health Sciences Nursing Department will be in the experimental group and 30 students in the I. control group. 30 students from Giresun University Faculty of Health Sciences Nursing Department will be in the second control group. Students in the experimental group will be given a motivational interview on quitting smoking for 40-50 minutes on average once a month for 6 months. No intervention will be applied to the students in the control groups during the research process, but a motivational interview will be applied once at the end of the research in terms of ethics. The data of the research will be collected with Personal Information Form, Fagerström Nicotine Addiction Test, Self-Efficacy Scale and Stage of Change Evaluation Form. In the study, repeated measurements will be made in the 1st month, 3rd month and 6th month. Necessary institutional permission and ethics committee approval will be obtained for the research. The analysis of the data will be done by an expert statistician in a computer environment.

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ordu, Turkey, 52200
        • Ordu University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Being a 1st, 2nd, and 3rd year student of the Nursing Department,
  • Continuing active education and training,
  • Smoker at least one cigarette a day,
  • Open to communication and cooperation, and
  • Students who volunteer to participate in the study will be included in the study.

Exclusion Criteria:

  • Fourth grade,
  • Having a serious psychiatric diagnosis (schizophrenia, bipolar disorder, psychotic disorder, etc.),
  • Receiving professional support for smoking cessation,
  • Changing schools during the research process and
  • Students who do not want to continue the research will be excluded from the research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Motivational interview will be done to the experimental group
Quitting smoking with motivational interviewing
No Intervention: I Control group
No intervention will be applied to the control group
No Intervention: II Control group
No intervention will be applied to the control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Efficacy Scale
Time Frame: 1st, 3rd, and 6th months
The scale was developed by Nicki, Remington and MacDonald in 1984. This scale, which was developed based on social learning theories, is related to the individual's belief that he or she can perform a desired behavior. This scale is used in smoking cessation studies. The scale was adapted to Turkish by Karancı. The scale consists of 25 questions, each of which consists of 5 items, and is likert type. Each item score in the scale ranges from 1 to 5. The individual rates the smoking status for each item in five categories ranging from "Not at all sure:1" to "Absolutely sure:5". The scores to be taken from the scale vary between 5-25, and as the score increases, the belief that one can quit smoking increases.
1st, 3rd, and 6th months
Fagerström Test for Nicotine Dependence
Time Frame: 1st, 3rd, and 6th months
Dr. The test developed by Karl Fagerström in 1978 to evaluate the level of addiction to nicotine; It was reconsidered by Fagerström, Heatherton and Kazlowki and the Fagerström Test for Nicotine Dependence was created. In Turkish Uysal et al. Adapted by in 2004. In the test, which consists of 6 questions in total, each question is given a different score. The scale consists of 6 questions and each item is scored as 0,1,2,3, and one of the answer options should be marked. 2nd, 3rd, 5th of the scale. Since the 6th and 6th questions are 0-1 points, the points that can be obtained from the scale range from 0-10. The highest score "10" indicates the highest degree of nicotine addiction, and the lowest score "0" indicates no nicotine addiction. According to the total scores obtained as a result of the test, it is defined as 0-2: very little dependence, 3-4: little dependence, 5: moderately dependent, 6-7: high dependence, and 8-10: very high dependence.
1st, 3rd, and 6th months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
quit smoking
Time Frame: 1st, 3rd, and 6th months
quit smoking
1st, 3rd, and 6th months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

April 12, 2023

Study Registration Dates

First Submitted

October 14, 2022

First Submitted That Met QC Criteria

November 28, 2022

First Posted (Actual)

December 6, 2022

Study Record Updates

Last Update Posted (Actual)

April 28, 2023

Last Update Submitted That Met QC Criteria

April 27, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quit Smoking

Clinical Trials on motivational interview

Subscribe